How do I set a price alert for NSCI.L?

To set a NSCI.L price alert on Stock Alarm Pro, navigate to the NSCI.L quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for NSCI.L?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for NSCI.L. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for NSCI.L?

Stock Alarm Pro supports over 125 trigger types for NSCI.L: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about NSCI.L price changes?

NSCI.L alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for NSCI.L alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for NSCI.L and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

NSCI.L Company Intelligence - Business Model, Drivers & Risks

NSCI.L(NSCI.L)

$53.12—Stale · unknown old

WatchlistAsk SA Chart

NSCI.L(NSCI.L)

LSE • Last print unknown ago

$53.12—Stale · unknown old

WatchlistAsk SA Chart Studio

NSCI.L(NSCI.L)

NSCI.L

NetScientific plc is a biotechnology investment and commercialization company focused on developing and scaling innovative healthcare technologies. The company primarily operates in the UK and Europe, leveraging its portfolio of companies that specialize in diagnostics, therapeutics, and digital health solutions, which positions it uniquely in the rapidly evolving healthcare landscape.

HealthcareBiotechnologylow - the company has a high reliance on variable costs associated with investment and operational expenditures in its portfolio companies.

Business Overview

01Investment returns from portfolio companies (unknown % of total)

02Licensing agreements and royalties from technology commercialization (unknown % of total)

NetScientific generates revenue primarily through strategic investments in its portfolio companies, which focus on innovative healthcare solutions. The company has a competitive advantage through its expertise in identifying and nurturing high-potential biotech firms, allowing it to capitalize on emerging trends in healthcare technology.

What Moves the Stock

Successful clinical trial results from portfolio companies

Partnerships or licensing deals that enhance revenue potential

Market adoption of technologies developed by portfolio companies

Regulatory approvals impacting portfolio company products

Watch on Earnings

Value of portfolio companiesReturn on investment from exits or partnershipsProgress in clinical trials of key assets

Risk Factors

Regulatory changes affecting the biotechnology sector

Technological disruption in healthcare solutions

Intense competition from other biotech investment firms

Rapid advancements in healthcare technology that could outpace portfolio development

Low liquidity as indicated by a current ratio of 0.28

Potential for increased operational costs without corresponding revenue growth

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - the biotechnology sector can be sensitive to economic cycles, as funding and investment in healthcare innovations may fluctuate with economic conditions.

Interest Rates

Interest rates affect NetScientific's cost of capital and the valuation of its portfolio companies. Higher rates could dampen investment activity in biotech, impacting growth potential.

Credit

minimal - the company has a manageable debt-to-equity ratio of 0.17, indicating limited reliance on external financing.

Live Conditions

Russell 2000 FuturesDow Jones FuturesS&P 500 Futures